Wed, April 19, 2023
Tue, April 18, 2023
Mon, April 17, 2023

Joseph Stringer Reiterated (CARA) at Buy and Held Target at $22 on, Apr 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-22-on-apr-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Buy and Held Target at $22 on, Apr 18th, 2023.

Joseph has made no other calls on CARA in the last 4 months.



There are 5 other peers that have a rating on CARA. Out of the 5 peers that are also analyzing CARA, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Joseph


  • Jason Gerberry of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $6 on, Wednesday, March 8th, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, March 7th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
  • Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023

Publication Contributing Sources